Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

NCT03229746 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Hydroxychloroquine
DRUG: vincristine
DRUG: azathioprine

Sponsor

Assiut University